Abadji V - Search Results

1

Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.

Papahatjis DP, Kourouli T, Abadji V, Goutopoulos A, Makriyannis A. Papahatjis DP, et al. Among authors: abadji v. J Med Chem. 1998 Mar 26;41(7):1195-200. doi: 10.1021/jm970277i. J Med Chem. 1998. PMID: 9544219

2

Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand.

Khanolkar AD, Abadji V, Lin S, Hill WA, Taha G, Abouzid K, Meng Z, Fan P, Makriyannis A. Khanolkar AD, et al. Among authors: abadji v. J Med Chem. 1996 Oct 25;39(22):4515-9. doi: 10.1021/jm960152y. J Med Chem. 1996. PMID: 8893848

3

Classical/non-classical cannabinoid hybrids; stereochemical requirements for the southern hydroxyalkyl chain.

Tius MA, Hill WA, Zou XL, Busch-Petersen J, Kawakami JK, Fernandez-Garcia MC, Drake DJ, Abadji V, Makriyannis A. Tius MA, et al. Among authors: abadji v. Life Sci. 1995;56(23-24):2007-12. doi: 10.1016/0024-3205(95)00182-6. Life Sci. 1995. PMID: 7776825

4

(-)-11-Hydroxy-7'-isothiocyanato-1',1'-dimethylheptyl-delta 8-THC: a novel, high-affinity irreversible probe for the cannabinoid receptor in the brain.

Guo Y, Abadji V, Morse KL, Fournier DJ, Li X, Makriyannis A. Guo Y, et al. Among authors: abadji v. J Med Chem. 1994 Nov 11;37(23):3867-70. doi: 10.1021/jm00049a002. J Med Chem. 1994. PMID: 7966145 No abstract available.

5

(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability.

Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, Pertwee RG, Makriyannis A. Abadji V, et al. J Med Chem. 1994 Jun 10;37(12):1889-93. doi: 10.1021/jm00038a020. J Med Chem. 1994. PMID: 8021930

6

Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations.

Pertwee RG, Fernando SR, Griffin G, Abadji V, Makriyannis A. Pertwee RG, et al. Among authors: abadji v. Eur J Pharmacol. 1995 Jan 5;272(1):73-8. doi: 10.1016/0014-2999(94)00618-h. Eur J Pharmacol. 1995. PMID: 7713152

7

Synthesis and biological evaluation of novel daunorubicin-estrogen conjugates.

Kasiotis KM, Magiatis P, Pratsinis H, Skaltsounis A, Abadji V, Charalambous A, Moutsatsou P, Haroutounian SA. Kasiotis KM, et al. Among authors: abadji v. Steroids. 2001 Oct;66(10):785-91. doi: 10.1016/s0039-128x(01)00110-6. Steroids. 2001. PMID: 11522342

8

The nicotinic acetylcholine receptor in its membrane environment.

Miller KW, Wood SC, Forman SA, Bugge B, Hill WA, Abadji V. Miller KW, et al. Among authors: abadji v. Ann N Y Acad Sci. 1991;625:600-15. doi: 10.1111/j.1749-6632.1991.tb33895.x. Ann N Y Acad Sci. 1991. PMID: 1711816 Review. No abstract available.

9

Ligand binding and modulation of cyclic AMP levels depend on the chemical nature of residue 192 of the human cannabinoid receptor 1.

Chin CN, Lucas-Lenard J, Abadji V, Kendall DA. Chin CN, et al. Among authors: abadji v. J Neurochem. 1998 Jan;70(1):366-73. doi: 10.1046/j.1471-4159.1998.70010366.x. J Neurochem. 1998. PMID: 9422383 Free article.

10

Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs.

Abadji V, Lucas-Lenard JM, Chin C, Kendall DA. Abadji V, et al. J Neurochem. 1999 May;72(5):2032-8. doi: 10.1046/j.1471-4159.1999.0722032.x. J Neurochem. 1999. PMID: 10217281 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters